EUCTR2008-001752-43-IT进行中（未招募）1 期
CARDIAC PROTECTION WITH SEVOFLURANE IN PATIENTS WITH HIGH RISK UNDERGOING HEART SURGERY. RANDOMIZED, CONTROLLED STUDY. - ND
OSPEDALE S. RAFFAELE0 个研究点目标入组 200 人开始时间: 2008年5月8日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •patients with aged more then 18 years; informed consent; surgery palnned for study
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •acute ongoing heart stroke ; troponin I > 1 ng/ml; previous ipersensibility to study drug; use of sulfonilurea, teofillina o allopurinolo;toracotomy;
研究者
相似试验
进行中（未招募）
不适用
Cardioprotective effect of sevoflurane versus propofol used during anesthesia and the postoperative period in patients undergoing coronary bypass surgery. Impact on critical care unit stay. A double-blind, randomized, controlled, prospective clinical study.Efecto cardioprotector del sevoflurano frente al propofol, utilizados durante la anestesia y el periodo postoperatorio en pacientes sometidos a cirugía de bypass coronario. Repercusión sobre la estancia en la unidad de críticos. Estudio clínico, prospectivo, controlado, randomizado y doble ciego.This study will evaluate the cardioprotective effects of sevoflurane versus propofol during anesthesia and sedation of patients undergoing coronary bypass surgery in terms of maintenance of cardiac function and reduction of stay in these units.Secondary Objectives:1. To compare the possible advantages and disadvantages of both regimens in terms of preservation/improvement or pulmonary, hepatic and renal side effects.MedDRA version: 8.1Level: LLTClassification code 10002323Term: Anesthesia generalEUCTR2006-003515-44-ESFRANCISCO JAVIER BELDA
进行中（未招募）
不适用
Sevoflurane on cardiac surgery: vantage to use during CECgeneral anestetic inalathory also during CECMedDRA version: 6.1Level: PTClassification code 10018060EUCTR2005-001574-27-ITAZIENDA OSPEDALIERA DI PERUGIA
进行中（未招募）
1 期
Can the heart drug enalapril prevent heart damage in patients with newly diagnosed breast cancer and lymphoma receiving chemotherapy?Prevention of cardiotoxicityMedDRA version: 20.0Level: PTClassification code 10048610Term: CardiotoxicitySystem Organ Class: 10007541 - Cardiac disordersEUCTR2017-001094-16-GBSouth Tees NHS Foundation Trust170
已完成
不适用
Desflurane-induced myocardial protection in cardiac surgeryPatients undergoing aortic valve replacementJPRN-UMIN000015004School of Medicine, Keio University184
尚未招募
Unknown
To Compare the Safety and Efficacy of Sevoflurane and Desflurane for Intraoperative Hemodynamics and Recovery in Pediatric Patients Undergoing Short Surgical Procedures Under spontaneous Respiration.CTRI/2023/07/054641Dr Varanasi Venkata Sri Bharadwaja